Correspondence re: Chokkalingam A. et al., Insulin-like growth factors and prostate cancer: a population-based case-control study in China. Cancer Epidemiol. Biomark. Prev., 10: 421-427, 2001.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Cancer Epidemiology, Biomarkers and Prevention

• Publication date

  2002-03-01

• Fields of study

  Medicine

• Identifiers
  PMID 11895887
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Insulin-like growth factors and prostate cancer: a population-based case-control study in China.

  2001cited by this paper
• Serum levels of insulin-like growth factor I (IGF-I), IGF-II, IGF-binding protein-3, and prostate-specific antigen as predictors of clinical prostate cancer.

  2000cited by this paper
• Insulin-like growth factor 1 and prostate cancer risk: a population-based, case-control study.

  1998cited by this paper
• Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia.

  1997cited by this paper
• Normal control of growth hormone secretion.

  1993cited by this paper

• Androgen Receptor Splice Variant AR3 Promotes Prostate Cancer via Modulating Expression of Autocrine/Paracrine Factors*

  2013cites this paper
• PALABRAS CLAVES: CANCER DE PROSTATA, MÉTODO DELPHI.

  2009cites this paper
• Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft.

  2007cites this paper
• Basal growth hormone concentrations in blood and the risk for prostate cancer: A case‐control study

  2005cites this paper
• Putative role of serum insulin-like growth factor–1 (IGF-1) and IGF binding protein-3 (IGFBP-3) levels in the development of prostate cancer in Arab men

  2005cites this paper